These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2956130)

  • 41. A practical dexamethasone suppression test to evaluate hirsute women.
    Wu CH
    Int J Gynaecol Obstet; 1982 Feb; 20(1):35-41. PubMed ID: 6126405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppression of plasma androgens by spironolactone in castrated men with carcinoma of the prostate.
    Walsh PC; Siiteri PK
    J Urol; 1975 Aug; 114(2):254-6. PubMed ID: 125803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of an oral contraceptive on adrenal and ovarian androgenic steroids.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1984 Jan; 63(1):12-4. PubMed ID: 6228751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ovarian contribution to peripherally derived serum C19 conjugates.
    Matteri RK; Stanczyk FZ; Cassidenti DL; Paulson RJ; Lobo RA
    J Clin Endocrinol Metab; 1992 Sep; 75(3):768-72. PubMed ID: 1387653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.
    Moghetti P; Castello R; Negri C; Tosi F; Magnani CM; Fontanarosa MC; Armanini D; Muggeo M
    Fertil Steril; 1995 Sep; 64(3):511-7. PubMed ID: 7641903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients.
    Abraham GE; Maroulis GB; Buster JE; Chang RJ; Marshall JR
    Obstet Gynecol; 1976 Apr; 47(4):395-402. PubMed ID: 130572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of hirsutism in women with flutamide.
    Marcondes JA; Minnani SL; Luthold WW; Wajchenberg BL; Samojlik E; Kirschner MA
    Fertil Steril; 1992 Mar; 57(3):543-7. PubMed ID: 1531466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
    J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of exercise on dehydroepiandrosterone sulphate and delta 4-androstenedione plasma levels in man.
    Velardo A; Pantaleoni M; Valerio L; Barini A; Marrama P
    Exp Clin Endocrinol; 1991 Mar; 97(1):99-101. PubMed ID: 1830847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism.
    Wild RA; Umstot ES; Andersen RN; Ranney GB; Givens JR
    Am J Obstet Gynecol; 1983 Jul; 146(6):602-6. PubMed ID: 6223527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The correlation between clinical and hormonal parameters in androgenisation.
    Pfeifer M; Prezelj J; Kocijancic A
    Acta Eur Fertil; 1989; 20(1):31-3. PubMed ID: 2528879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hirsutism caused by an androgen-producing ovarian tumor. A case of arrhenoblastoma.
    Lunde O; Djoseland O
    J Endocrinol Invest; 1986 Dec; 9(6):513-6. PubMed ID: 3033052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low-dose spironolactone in the treatment of female hirsutism.
    Ylöstalo P; Heikkinen J; Kauppila A; Pakarinen A; Järvinen PA
    Int J Fertil; 1987; 32(1):41-5. PubMed ID: 2880814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effects of spironolactone in polycystic ovary syndrome.
    Milewicz A; Silber D; Kirschner MA
    Obstet Gynecol; 1983 Apr; 61(4):429-32. PubMed ID: 6828272
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combination of cyproterone acetate and natural estrogens in the treatment of hirsutism].
    Pugeat M; Nicolas MH; Déchaud H; Elmidani M
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1057-62. PubMed ID: 1839798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgens in hirsute women referred for electroepilation.
    Fogh H; Worm AM; Forkert B; Bennett P
    Acta Derm Venereol; 1989; 69(2):179-82. PubMed ID: 2564241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.